|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.843
|
|
|
|
flavonoid metabolic process
|
GO:0009812 |
8 |
0.717
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.635
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.632
|
|
|
|
negative regulation of collagen metabolic process
|
GO:0010713 |
3 |
0.611
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
9 |
0.610
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.553
|
|
|
|
regulation of n methyl d aspartate selective glutamate receptor activity
|
GO:2000310 |
1 |
0.510
|
|
|
|
negative regulation of activation of jak2 kinase activity
|
GO:1902569 |
1 |
0.508
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
7 |
0.496
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.493
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
4 |
0.461
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.429
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.392
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.386
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.386
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.384
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.373
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.372
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.366
|
|
|
|
energy homeostasis
|
GO:0097009 |
3 |
0.365
|
|
|
|
androgen metabolic process
|
GO:0008209 |
9 |
0.342
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.339
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.338
|
|
|
|
galactose metabolic process
|
GO:0006012 |
4 |
0.332
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.323
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
9 |
0.321
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.315
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.312
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.308
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.301
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
23 |
0.297
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.295
|
Human |
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.292
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.290
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.286
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.284
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.282
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.282
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.281
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.278
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.277
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.276
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.274
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.270
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.270
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.266
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.266
|
|
|
|
response to activity
|
GO:0014823 |
0 |
0.265
|
|
|
|
negative regulation of bile acid biosynthetic process
|
GO:0070858 |
3 |
0.261
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.255
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.249
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.248
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.248
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.242
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.241
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.232
|
Human |
|
|
lipid modification
|
GO:0030258 |
84 |
0.223
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.223
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.223
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.218
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.215
|
Human |
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.214
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.211
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.211
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
30 |
0.211
|
|
|
|
regulation of energy homeostasis
|
GO:2000505 |
1 |
0.206
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.201
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.200
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.198
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.197
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.195
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.195
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.192
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
11 |
0.190
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.189
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.189
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.188
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.188
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.185
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.183
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.182
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.179
|
|
|
|
system process
|
GO:0003008 |
349 |
0.178
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.176
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.175
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.169
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.167
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.165
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.165
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.162
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.160
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.157
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
15 |
0.155
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.150
|
Human |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.149
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.146
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.143
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.141
|
Human |
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.141
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.141
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.139
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.137
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.137
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.137
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.136
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.133
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.133
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.131
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.128
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.127
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
14 |
0.127
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.127
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.126
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.124
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.122
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
18 |
0.122
|
|
|
|
cellular response to reactive nitrogen species
|
GO:1902170 |
2 |
0.122
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.120
|
|
|
|
response to leucine
|
GO:0043201 |
2 |
0.119
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.119
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.117
|
Human |
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.117
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.115
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.115
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.113
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.112
|
|
|
|
response to epinephrine
|
GO:0071871 |
2 |
0.111
|
|
|
|
response to amino acid
|
GO:0043200 |
14 |
0.110
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.109
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.109
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.107
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.106
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.106
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.105
|
|
|
|
bile acid metabolic process
|
GO:0008206 |
14 |
0.105
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.103
|
|
|
|
response to lithium ion
|
GO:0010226 |
2 |
0.102
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.102
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.102
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
24 |
0.100
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.099
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.097
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.097
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.095
|
Zebrafish |
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.094
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.093
|
Human |
|
|
response to muscle activity
|
GO:0014850 |
0 |
0.093
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.093
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.092
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.089
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.087
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.086
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.086
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.084
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.081
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.081
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
23 |
0.081
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.081
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.080
|
|
|
|
response to purine containing compound
|
GO:0014074 |
40 |
0.079
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.079
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.078
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.077
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
25 |
0.077
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.077
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.077
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.076
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.075
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.074
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
63 |
0.074
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.074
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.074
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.073
|
Human |
|
|
regulation of receptor activity
|
GO:0010469 |
47 |
0.073
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.072
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.072
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.072
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.071
|
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.071
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.071
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.071
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.071
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.069
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.069
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
8 |
0.068
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.066
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.066
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.065
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.064
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.063
|
|
|
|
nucleoside biosynthetic process
|
GO:0009163 |
26 |
0.063
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.063
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.063
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.062
|
|
|
|
glycolytic process
|
GO:0006096 |
17 |
0.062
|
|
|
|
atp biosynthetic process
|
GO:0006754 |
11 |
0.062
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.062
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.061
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.061
|
Human |
|
|
xenobiotic transport
|
GO:0042908 |
1 |
0.061
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.060
|
|
|
|
response to caffeine
|
GO:0031000 |
3 |
0.059
|
|
|
|
nucleoside triphosphate biosynthetic process
|
GO:0009142 |
20 |
0.059
|
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.058
|
|
|
|
ornithine metabolic process
|
GO:0006591 |
3 |
0.058
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.058
|
|
|
|
negative regulation of receptor activity
|
GO:2000272 |
15 |
0.058
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.058
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.057
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.057
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
7 |
0.057
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.057
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.057
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.057
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.056
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
27 |
0.055
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.055
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.055
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.055
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.054
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
9 |
0.053
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.053
|
Human |
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.053
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
4 |
0.052
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.052
|
Human |
|
|
nuclear transport
|
GO:0051169 |
179 |
0.052
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.052
|
|
|
|
positive regulation of smooth muscle cell proliferation
|
GO:0048661 |
14 |
0.051
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.051
|
Human |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.051
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.051
|
|
|
|
regulation of glycolytic process
|
GO:0006110 |
10 |
0.051
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.050
|
|
|
|
nucleoside monophosphate biosynthetic process
|
GO:0009124 |
19 |
0.050
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.050
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.050
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.049
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.049
|
|
|
|
purine ribonucleoside monophosphate biosynthetic process
|
GO:0009168 |
16 |
0.049
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.049
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.049
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.049
|
|
|
|
negative regulation of collagen biosynthetic process
|
GO:0032966 |
2 |
0.048
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.048
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.048
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.048
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.048
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.048
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.047
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.047
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
38 |
0.047
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.046
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.046
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.046
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.045
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.045
|
|
|
|
memory
|
GO:0007613 |
3 |
0.045
|
|
|
|
signal transduction involved in regulation of gene expression
|
GO:0023019 |
1 |
0.045
|
|
|
|
organic acid transport
|
GO:0015849 |
65 |
0.045
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.045
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.045
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.045
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.045
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.045
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.044
|
Human |
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.044
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.044
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.044
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.044
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.044
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.043
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.043
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.043
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.043
|
|
|
|
cellular respiration
|
GO:0045333 |
21 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.043
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
7 |
0.043
|
|
|
|
respiratory electron transport chain
|
GO:0022904 |
7 |
0.043
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.043
|
|
|
|
negative regulation of cholesterol storage
|
GO:0010887 |
4 |
0.042
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.042
|
|
|
|
response to monoamine
|
GO:0071867 |
7 |
0.042
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.042
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.042
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.042
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.042
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.042
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.041
|
|
|
|
startle response
|
GO:0001964 |
3 |
0.041
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.041
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.041
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.041
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.041
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.040
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.040
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.040
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.040
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.039
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.039
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.039
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.039
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.039
|
|
|
|
cellular response to fatty acid
|
GO:0071398 |
8 |
0.039
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.039
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
30 |
0.038
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.038
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.038
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.038
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.038
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
23 |
0.037
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.037
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.037
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.037
|
|
|
|
ribonucleoside monophosphate biosynthetic process
|
GO:0009156 |
17 |
0.037
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.037
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.037
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.037
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.036
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.036
|
|
|
|
lymphatic endothelial cell fate commitment
|
GO:0060838 |
2 |
0.036
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.036
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.036
|
|
|
|
regulation of glutamate receptor signaling pathway
|
GO:1900449 |
6 |
0.036
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.036
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.035
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
65 |
0.035
|
|
|
|
positive regulation of oxidoreductase activity
|
GO:0051353 |
26 |
0.035
|
Human |
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.035
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.035
|
|
|
|
regulation of transcription involved in lymphatic endothelial cell fate commitment
|
GO:0060849 |
2 |
0.034
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.034
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.034
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
1 |
0.034
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.034
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.034
|
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
3 |
0.033
|
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.033
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.033
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.033
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.033
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.033
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.033
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.032
|
|
|
|
negative regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033144 |
18 |
0.032
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
18 |
0.032
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.032
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
6 |
0.032
|
|
|
|
positive regulation of epithelial cell differentiation
|
GO:0030858 |
14 |
0.032
|
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.032
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.032
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.032
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.032
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.031
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.031
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.031
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.031
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.031
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.031
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.031
|
|
|
|
positive regulation of atp metabolic process
|
GO:1903580 |
20 |
0.031
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.030
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.030
|
|
|
|
mating
|
GO:0007618 |
1 |
0.030
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.030
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.030
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.030
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.030
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.029
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.029
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
25 |
0.029
|
|
|
|
drug export
|
GO:0046618 |
1 |
0.029
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.029
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
43 |
0.029
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.029
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.029
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.029
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.028
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.028
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.028
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.028
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.028
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.028
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.028
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.028
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.028
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.028
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.028
|
Human |
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.028
|
|
|
|
ribonucleoside triphosphate biosynthetic process
|
GO:0009201 |
12 |
0.028
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.027
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.027
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
31 |
0.027
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.027
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.027
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.027
|
|
|
|
negative regulation of sequestering of triglyceride
|
GO:0010891 |
5 |
0.027
|
|
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.027
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.027
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.027
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.027
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.027
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.027
|
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
6 |
0.027
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.027
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.027
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
20 |
0.027
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.026
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.026
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.026
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.026
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.026
|
|
|
|
retinoic acid receptor signaling pathway
|
GO:0048384 |
13 |
0.026
|
Human |
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.026
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.026
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.025
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.025
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
76 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.025
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.025
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
3 |
0.025
|
|
|
|
microvillus assembly
|
GO:0030033 |
2 |
0.025
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.025
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.025
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
11 |
0.025
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.025
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.025
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.025
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.025
|
|
|
|
negative regulation of acute inflammatory response
|
GO:0002674 |
3 |
0.025
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
72 |
0.025
|
|
|
|
regulation of activation of janus kinase activity
|
GO:0010533 |
6 |
0.025
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.025
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
17 |
0.024
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.024
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.024
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.024
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.024
|
|
|
|
lipid homeostasis
|
GO:0055088 |
39 |
0.024
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
27 |
0.024
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.024
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.024
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
46 |
0.024
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.023
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.023
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.023
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.023
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.023
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.023
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.023
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
22 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.023
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.023
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.022
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.022
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.022
|
|
|
|
regulation of cellular carbohydrate catabolic process
|
GO:0043471 |
11 |
0.022
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.022
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.022
|
|
|
|
purine nucleoside triphosphate biosynthetic process
|
GO:0009145 |
11 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.022
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.022
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.022
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.022
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.022
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.022
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.022
|
|